PAHC
Research Snapshot
Static fundamentals, valuation context, and investor signals for Phibro Animal Health Corporation (PAHC).
DCF ready
Valuation
N/A
EV/FCF, N/A FCF yield
Quality
16.9%
ROIC, 3.2% FCF margin
Growth
10.1%
5Y sales (revenue) CAGR
Balance sheet
0.0x
Debt/equity, 2.8x current ratio
Superinvestors
1
Top: Polen Capital Management (0.0%)
Strengths to research
- Revenue compounded at 10.1% over five years.
- Free cash flow compounded at 10.6% over five years.
- ROIC is strong at 16.9%.
- Debt/equity looks manageable at 0.0x.
Watchouts
- Valuation multiples are limited or unavailable.
Annual data: 10 periods
Quarterly data: 24 periods
Stock snapshot: May 25, 2026
Static dataset: May 25, 2026
Quality Scorecard
Build-time composite score for PAHC.
Grade C
52
/ 100
Financial Charts
No financial data available for PAHC (annual).
1 superinvestors own PAHC
Current quarter ownership and quarter-over-quarter share changes.
Superinvestor ownership
| Fund | Shares | Value | % Portfolio | QoQ Change |
|---|---|---|---|---|
| Polen Capital Management Polen Capital Management | 6,775 | $375,000 | 0.00% | 0.0% |